These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6968872)

  • 21. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function.
    Hercend T; Meuer S; Brennan A; Edson MA; Acuto O; Reinherz EL; Schlossman SF; Ritz J
    J Exp Med; 1983 Nov; 158(5):1547-60. PubMed ID: 6355362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypes of human natural killer cell populations detected with monoclonal antibodies.
    Zarling JM; Clouse KA; Biddison WE; Kung PC
    J Immunol; 1981 Dec; 127(6):2575-80. PubMed ID: 7299137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure.
    Hercend T; Meuer S; Brennan A; Edson MA; Acuto O; Reinherz EL; Schlossman SF; Ritz J
    Cell Immunol; 1984 Jul; 86(2):381-92. PubMed ID: 6610481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
    Ziegler-Heitbrock HW; Fütterer A; Rumpold H; Kraft D; Munker R; Riethmüller G
    Clin Exp Immunol; 1984 Nov; 58(2):470-7. PubMed ID: 6333947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon production and tumor cell killing by human lymphocytes stimulated in mixed-lymphocyte culture.
    Peterman GM; Stanton GJ; Altman LC; Klimpel GR
    Cell Immunol; 1984 Apr; 85(1):114-24. PubMed ID: 6201284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a human T cell clone with the cytotoxic T lymphocyte and natural killer-like cytotoxic function against autologous mammary carcinoma and K562 line.
    Sato T; Okubo M; Wada Y; Sato N; Kikuchi K
    Jpn J Cancer Res; 1989 Jul; 80(7):655-61. PubMed ID: 2507488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line.
    Howell DN; Andreotti PE; Dawson JR; Cresswell P
    J Immunol; 1985 Feb; 134(2):971-6. PubMed ID: 3871222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the natural killer-like lymphocytes in rheumatoid synovial fluid.
    Goto M; Zvaifler NJ
    J Immunol; 1985 Mar; 134(3):1483-6. PubMed ID: 3968425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity and phenotype of IL-2 expanded clones of human large granular lymphocytes.
    Allavena P; Ortaldo JR
    Diagn Immunol; 1983; 1(3):162-7. PubMed ID: 6209054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization by monoclonal antibodies of the cytotoxic effector cells in human peripheral blood mononuclear cells reactive against anchorage-dependent tumour cell lines.
    Chang ZL; Hoffman T; Stevenson HC; Trinchieri G; Herberman RB
    Scand J Immunol; 1983 Nov; 18(5):451-9. PubMed ID: 6648368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
    Gehrz RC; Rutzick SR
    Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lymphocyte subpopulations involved in cytotoxicity generated by co-culture with autologous and allogeneic Epstein-Barr virus-transformed cell line.
    Minakuchi J; Yata J
    Tohoku J Exp Med; 1988 Jun; 155(2):107-15. PubMed ID: 2850641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
    Sibbitt WL; Mathews PM; Bankhurst AD
    J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of human natural killer recognition demonstrated by cloned effector cells and differential blocking of cytotoxicity with monoclonal antibodies.
    Pawelec G; Newman W; Schwulera U; Wernet P
    Cell Immunol; 1985 Apr; 92(1):31-40. PubMed ID: 3865716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.